HCV - Liver / Kidney Transplantation

FDA Alert Warns of Elevated Risk of Death in Liver Transplant Recipients Who Switch to Rapamune (Sirolimus)
6-16-2009

Kidney Disease in Patients with Chronic Hepatitis C
9/23/08

Older Donor Liver Grafts May Be Suitable for Chronic Hepatitis C Patients Requiring Transplantation
9/05/08

Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation
6/10/08

Marijuana Use Sparks Liver Transplant Controversy
6/06/08

FibroScan Liver Stiffness Measurement Distinguishes Fast and Slow Fibrosis Patterns after Liver Transplantation
5/16/08

Prophylaxis with Pegylated Interferon Alfa-2a (Pegasys) plus Ribavirin vs No Prophylaxis after Liver Transplantation - 11/27/07

Sodium Levels Can Help Predict Outcomes before and after Liver Transplantation   - 8/07/07

Treatment of Recurrent Hepatitis C in Liver Transplant Recipients     - 7/10/07

Response to PegIntron/ribavirin Leads to Stabilization of Fibrosis in Liver Transplant Recipients  - 5/01/07

Pegylated Interferon/ribavirin Therapy Results in Low SVR Rates after Liver Transplantation in HIV-HCV Coinfected Patients  - 3/27/07

Sustained Virological Response Improves Fibrosis Progression and Reduces Mortality after Liver Transplantation   2/23/07